Member Info for AquaeSulis01

You tell us Od, as you obviously have access to sales information that the rest of us, including Tyndall who have recently increased their stake, have not got. Would you care to divulge your source and what the numbers actually are?

Circa 13 mins in
https://ukinvestormagazine.co.uk/top-stock-picks-for-2022-with-alan-green/?mc_cid=fc707210a7&mc_eid=47d95d88cc

That will be the 98,618,425 warrants worth 0.75p o/s you are talking about bitcoin the rest having already been exercised

Further Compson are a distributer I believe with access to the Alibaba website. "Biofarma Group is the new Italian group of companies that formulates, manufactures and packages food supplements, medical devices, probiotic-based drugs and cosmetics, exclusively for third parties" so just missing the "third party" and Pierce Group have the exclusive rights for LPLDL to the Chinese market, subject to minimum order quantities being obtained

Hi mol,

Compson are a Taiwanese company
https://optibiotix.com/optibiotix-leads-sector-with-surging-post-covid-sales-figures/

"As part of our growth strategy, our reach now spans 160 countries within three years of product launches,” continued O’Hara. “In the last six months, we have signed new contracts with Compson Biotechnology in Taiwan, Inscobee Inc. in South Korea and Bioscience Marketing in Malaysia for LPLDL® and our finished product, CholBiome®."

H&B do need to up their game though. The strawberry Meal replacement shake has been out of stock for months now, and my recent order from the H&B online store which should have been a guaranteed delivery for last Saturday failed to arrive and a note from hermes stated it had been returned to the H&B warehouse. Still no forecast provided by H&B for re-delivery.

Having re-listened to the Alan Green/Adam Jones interview, what Adam said was that they would be drilling right up to Christmas with two drills at HR3 Baileston producing lots of core samples for analysis so not sure that equals lots of news. Also, re Creswick, the new drill that is expected to arrive is ideally suited for producing lots of core for the nuggety gold they anticipate finding in the veins, no doubt to coincide post assay results which should confirm they have the geology mapping spot on.

Zeon, the ingredients as shown on the site under FAQ are:

Maize Starch, Maltodextrin, AxisBiotix-Ps Complex, Potassium Chloride, Hydrolysed Rice Protein, Magnesium Sulphate, Manganese Sulphate.

The AxisBiotix-Ps Complex:

Bifidobacterium animals

Levilactobacillus brevis

Limosilactobacillus reuteri

Lactococcus lactis cremoris

belgrano, noting the the early hours of the morning timing of your post, a good night's sleep will also do wonders for any worry lines and it's free :)

Then I would go with the FAQ page as it is more recent Chris, suggesting the recipe was changed since the May 20 presentation.

Chris, almost 20 mins in on the Share Profit Presentation available for free on the Skinbiotherapeutics website
https://www.skinbiotherapeutics.com/stuart-ashman-presenting-at-the-share-profits-virtual-show-on-saturday-9th-may-2020/

Recent Warrants that have been exercised being sold for a quick profit I suspect

belgrano, skinbiotix is a lysate of the Lactobacillus Rhamnoses bacterium, Axisbiotix is a blend of 6 live bacteria so unless one is Lactobacillus Rhamnoses there will be no similarity. What I would say is that Lactobacillus Rhamnoses is available as a live probiotic in oral form but I am not aware of any anti-ageing claims for it taken this way

Thinking of asking for a refund on my ECR Advent Calendar, awful lot of empty windows

Yes, the LTH's here deserve a change of luck fingers crossed you have a Happy Christmas and a prosperous New Year

and if we were just talking about an isolated sale to fund a divorce settlement I would understand totally, but ubnfortunately we are not. Full list of transactions taken from the RNS announcements below:

Date Buy Sell
No Shares Price Value No Shares Price Value
17/09/14 750000 0.295 £221,250.00
11/12/15 71000 0.14 £9,940.00
07/12/17 250000 0.1225 £30,625.00
05/01/18 250000 0.615 £153,750.00
29/01/18 278720 0.122 £34,003.84
12/06/18 403770 1.21 £488,561.70
15/04/19 307970 0.29 £89,311.30
15/04/19 307970 1.361 £419,147.17
22/01/21 1650000 0.53919 £889,663.50

Casapinos, you certainly did well to jump out at the IPO price, but not to jump in at today's fall is somewhat niaive in my opinion based on your superficial profit analysis. Let me give you two counter stats to consider:
Firstly, regarding the profit, note "After accounting for £9.4 million of exceptional costs relating to the IPO in June 2021 and share-based payments of £7.7 million, profit before tax reduced by 17% to £19.7 million (2020*: £23.7 million)", in other words profit without once off costs associated with the IPO went up to £30.1M.
Secondly, the revenue growth was reported as 29% on the 7th Oct 2021 when the share price eventually settled circa 155p, this figure was confirmed today so nothing material has changed yet the share price is now 91p. This makes it an unwarranted fall in my book and hence a buy.

For DS Smith's first half, UBS analyst Mikael Doepel has penciled-in a rise in revenues from approximately £2.9bn one year ago to £3.25bn, putting him roughly in line with the analyst consensus.
Jab, for info
However, the international packaging company's earnings before interest and taxes were pegged to come in at £288m (consensus: £275m), thanks to an improvement in its margins from 8.0% to 8.9%.

The analyst attributed the improved margin to higher average corrugated volume growth and average box prices, while noting that increased costs meaning that its overall performance was well in line with company expectations.

"Looking ahead, we expect the company to guide for continued (albeit moderating) volumes growth in the second half (UBSe +3%), and high confidence in covering cost inflation with higher box prices."

Bo77ock7 there is nothing wrong with using options to buy and sell shares at the right time, i.e. once the company is profitable but not whilst the company is borrowing hand over fist to stay solvent

Jdubya, I genuinely hope this company delivers for you. One thing has prevented me from taking a chance on the long term potential here, and that is the fact that the CEO does not demonstrate the same faith in his company as you and other LTHs do. He has repeatedly sold shares over the years to the tune of over £2.17m and failed to put his hand in his pocket to buy at the current low market price, as have other directors.